Evidence map›Paper›PMID 35028779›Full record

ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2022

Visual evoked potential and nerve conduction study findings in patients recovered from COVID-19.

Asli Koskderelioglu, Neslihan Eskut, Pinar Ortan, Hulya Ozkan Ozdemir, Selma Tosun

Open access · bronzeAbstract read
In one paragraph

Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Visual evoked potential abnormalities in patients with COVID-19.Revista da Associacao Medica Brasileira (1992) · 2024
    Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Asli KoskdereliogluDepartment of Neurology, University of Health Sciences, Izmir Bozyaka Education and Research Hospital, Saim Cikrikci cad No: 59, Bozyaka, Karabaglar, 35170, Izmir, Turkey. copura@gmail.com.ORCID http://orcid.org/0000-0002-7828-6382
Neslihan EskutDepartment of Neurology, University of Health Sciences, Izmir Bozyaka Education and Research Hospital, Saim Cikrikci cad No: 59, Bozyaka, Karabaglar, 35170, Izmir, Turkey.
Pinar OrtanDepartment of Neurology, University of Health Sciences, Izmir Bozyaka Education and Research Hospital, Saim Cikrikci cad No: 59, Bozyaka, Karabaglar, 35170, Izmir, Turkey.
Hulya Ozkan OzdemirDepartment of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Izmir Bozyaka Education and Research Hospital, Saim Cikrikci cad No:59, Bozyaka, Karabaglar, 35170, Izmir, Turkey.
Selma TosunDepartment of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Izmir Bozyaka Education and Research Hospital, Saim Cikrikci cad No:59, Bozyaka, Karabaglar, 35170, Izmir, Turkey.
Izmir University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveCOVID-19 infection is associated with peripheral neuropathy. However, subclinical neurological involvement may occur anytime, and diagnostic methods that reveal this subclinical involvement are not well established. We aimed to assess the subclinical neurological involvement by visual evoked potential (VEP) measurements and nerve conduction studies (NCS) and explore the relationship between neurological electrophysiological findings and the severity of COVID-19 infection.

methodsSeventy-six patients recovered from COVID-19 infection, and 44 healthy controls were enrolled in the study. Patients were assessed for clinical and demographic parameters. NCS and VEP analyses were performed to detect any peripheral neuropathy or optic neuropathy in both groups.

resultsNone of the COVID-19 patients had electrophysiological evidence of peripheral neuropathy. However, patients with COVID-19 pneumonia had significant abnormalities in several peripheral nerve measurements compared to patients without pneumonia. Although P100 parameters did not differ significantly between patients and controls, 12 patients with COVID-19 had prolonged P100 latencies.

conclusionsWe detected subclinical afferent visual pathway abnormality evaluated by VEP analysis. In addition, we found subtle electrophysiological features in the NCS of the patients presented with COVID-19 pneumonia. However, our findings did not fortify the diagnosis of peripheral neuropathy or optic neuropathy. Further studies are needed to determine the characteristics of COVID-19-related peripheral neuropathy/optic neuropathy whether it has distinct clinical features and disease course.

Indexed as

COVID-19Optic Nerve DiseasesEvoked Potentials, VisualHumansNeural ConductionSARS-CoV-2COVID-19Nerve conduction studiesNeuropathyOptic neuropathySARS-COV-2Visual evoked potential

Identifiers

PMID35028779
PMCPMC8758232
OpenAlexW4205911064

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.